BioCentury
ARTICLE | Company News

Evotec OAI, SEO in service deal

April 26, 2001 7:00 AM UTC

Evotec OAI (NMarkt:EVT) will use its VLiP transmembrane protein screening technology to develop an assay for one of Serono's (SWX: SEO, NYSE: SRA) cellular targets. EVT also will use its EVOscreen tec...